alexa Katalin Prokai-Tatrai | University of North Texas Healt
ISSN : 2153-2435

Pharmaceutica Analytica Acta
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Katalin Prokai-Tatrai

Research associate professor Department of Pharmacology,University of North Texas Health Science Center,USA
Katalin Prokai-Tatrai, PhD, recently joined the UNT Health Science Center as a research associate professor in the Department of Pharmacology and Neuroscience. Dr. Prokai-Tatrai was formerly an associate scientist in the Department of Pharmacology and Therapeutics at the University of Florida. She earned a bachelor of science degree in chemical engineering, a master of science degree in chemistry and a doctorate in organic chemistry from the University of Veszprem in Hungary, graduating summa cum laude with all three degrees. As a medicinal chemist, Dr. Prokai-Tatraiâ??s research interests include drug discovery on central nervous system agents using neuropeptides or peptidomimetics as lead compounds, the application of pro-drug approaches to improve brain-targeting of therapeutic agents, and understanding how phenolic antioxidants protect neurons against reactive oxygen species with a special emphasis on estrogens as protective agents. A native of Hungary, Dr. Prokai-Tatrai currently resides in Mansfield with her husband, Laszlo, and 8-year-old son, Marcel. Her oldest son, David, is currently a college student at the University of Florida.
Research Interest
Medicinal and pharmaceutical chemistry with special emphasis on drug design and non-invasive drug delivery into the central nervous system. Neuroprotective strategies with special emphasis on the aging and injured brain. Neuropeptides as lead compounds for central nervous system drug design. Combinatorial lead optimization.

“All in the Mind”? Brain-Targeting Chemical Delivery System of 17β-Estradiol (Estredox) Produces Significant Uterotrophic Side Effect

Katalin Prokai-Tatrai, Szabolcs Szarka, Vien Nguyen, Fatima Sahyouni, Cary Walker, Shastazia White, Tatjana Talamantes and Laszlo Prokai

Research Article: Pharm Anal Acta 2011, S7:002

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version